LENZ THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-65.4M | $19.8M |
| FY2021 | — | $384.1M | $377.0M |
| FY2022 | — | $-24.2M | $47.7M |
| FY2023 | — | $-92.7M | $35.1M |
| FY2024 | — | $204.1M | $20.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-65.4M | $19.8M |
| FY2021 | — | $384.1M | $377.0M |
| FY2022 | — | $-24.2M | $47.7M |
| FY2023 | — | $-92.7M | $35.1M |
| FY2024 | — | $204.1M | $20.2M |